MedPath

A study to compare combination therapy of diabetic and anti hypertensive drugs with only anti hypertensive drug in patients with Chronic kidney disease

Not Applicable
Conditions
Health Condition 1: N189- Chronic kidney disease, unspecified
Registration Number
CTRI/2023/11/060195
Lead Sponsor
Dr Nithesh Babu R
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Gfr greater than 25 ml/min/m2

2. Urine albumin creatinine ratio greater than 30 mg/g with or without hypertension

3. Type 2 Diabetes mellitus

4. Hypertension

Exclusion Criteria

1. Patients not willing to give informed consent

2. Patients with end stage renal disease

3. Patients with acute renal failure

4. Patients with albumin creatinine ratio less than 30 mg/g

5. Pregnant and lactating mothers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Estimation of EGFR and Urine albumin creatinine ratioTimepoint: Every month for 3 months
Secondary Outcome Measures
NameTimeMethod
Blood pressure, lipid profile, serum creatinine, HbA1c, fasting glucose and rates of clinical adverse events such as myocardial infarction, stroke or end-stage renal diseaseTimepoint: 3 MONTHS
© Copyright 2025. All Rights Reserved by MedPath